Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 11/20 | 0.61 |
| ▸ | LTA4H | P09960 | 2/20 | 0.60 |
| ▸ | BCHE | P06276 | 3/20 | 0.59 |
| ▸ | ACHE | P22303 | 3/20 | 0.59 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.52 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.52 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6751621 | 0.99 | ESR1 (0.60) | ESR1LTA4HBCHEACHEMAOB | |
| SCHEMBL6748780 | 0.94 | LTA4H (0.56) | ESR1LTA4HBCHEACHEMAOB | |
| Hydrochloric Acid SCHEMBL6745263 | 0.93 | LTA4H (0.55) | ESR1LTA4HBCHEACHEMAOB | |
| SCHEMBL6744827 | 0.90 | LTA4H (0.60) | ESR1LTA4HBCHEACHEPSMB1 | |
| Hydrochloric Acid SCHEMBL6749948 | 0.89 | LTA4H (0.58) | ESR1LTA4HBCHEACHEPSMB1 | |
| Hydrochloric Acid SCHEMBL6751611 | 0.85 | ESR1 (0.66) | ESR1ESR2 | |
| SCHEMBL6748810 | 0.85 | ESR1 (0.63) | ESR1ESR2 | |
| SCHEMBL7442980 | 0.83 | LTA4H (0.58) | ESR1LTA4HPSMB1PSMB5PSMB2 | |
| SCHEMBL7117571 | 0.83 | MEN1 (0.56) | ESR1MAOB | |
| SCHEMBL6744378 | 0.83 | ESR1 (0.58) | ESR1LTA4HESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6703407-B1 | TREATMENT OF MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION | ELI LILLY AND COMPANY | 2004-03-09 | — | — | US | disclosed |
| US-6407243-B1 | POSTMEMOPAUSE DISEASES | ELI LILLY AND COMPANY | 2002-06-18 | — | — | US | disclosed |
| EP-0774966-A4 | BENZOFURAN COMPOUNDS, COMPOSITIONS, AND METHODS | LILLY CO ELI (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0774966-A1 | BENZOFURAN COMPOUNDS, COMPOSITIONS, AND METHODS | ELI LILLY AND COMPANY (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996009040-A1 | BENZOFURAN COMPOUNDS, COMPOSITIONS, AND METHODS | ELI LILLY AND COMPANY (US) | 1996-03-28 | — | — | WO | disclosed |